Add BrightSurf on Google Email

Effect of text messaging on COVID-19 vaccination uptake

A randomized clinical trial involving 16,000 participants found that receiving text messages had no significant impact on COVID-19 vaccination rates compared to telephone calls. The study suggests that alternative communication methods may be more effective in promoting vaccine uptake.

SourceJAMA Network·JournalJAMA Network Open·DateJun 13, 2022

Promising results for chemo-immunotherapy combination against pancreatic cancer, Penn study finds

Researchers found that combining chemotherapy with immunotherapy increased one-year survival rates for patients with advanced pancreatic cancer, with anti-PD-1/chemo regimen showing the highest response. The study identified key immune system biomarkers associated with better outcomes, offering new hope for precision oncology.

SourceUniversity of Pennsylvania School of Medicine·JournalNature Medicine·TypeObservational study·DateJun 3, 2022

Community-engagement preventive intervention promotes mental health of Bhutanese families in Western Massachusetts

A peer-led, family-centered preventive intervention is being tested to reduce stress, anxiety, and depressive symptoms among Bhutanese immigrants. The program, developed by Kalpana Poudel-Tandukar, uses problem management plus (PMP) and addresses multiple stressors, resulting in improved coping skills and social networking.

SourceUniversity of Massachusetts Amherst·JournalBMJ Open·TypeRandomized controlled/clinical trial·DateJun 1, 2022

Baby-OSCAR trial evaluates if selective early treatment of PDA reduces death or BPD at 36 weeks in extreme preterm babies

Researchers found no evidence that early selective treatment with ibuprofen reduces death or moderate to severe bronchopulmonary dysplasia in extreme preterm infants. However, treatment reduced the risk of an open patent ductus arteriosus and surgical treatment for a symptomatic PDA.

SourcePediatric Academic Societies·TypeRandomized controlled/clinical trial·DateApr 22, 2022

Online program improves well-being of stroke survivors

A new online program has been shown to improve health-related quality of life among adult stroke survivors. The study found that participants who received access to the program had higher scores on health-related quality of life and reported fewer problems with personal care and daily activities.

SourceFlinders University·JournalPLOS Medicine·TypeRandomized controlled/clinical trial·DateApr 19, 2022

Researchers outline need for new approach to COVID-19 vaccine testing

Researchers at Rutgers University propose a new approach to COVID-19 vaccine testing by combining conventional and challenge trials. This parallel approach, called Combining Conventional and Challenge trials (CCC), aims to facilitate faster and more accurate vaccine assessment and more effective pandemic response.

SourceRutgers University·JournalPharmacoepidemiology and Drug Safety·TypeCommentary/editorial·DateApr 12, 2022

Effectiveness of letters to increase health insurance enrollment

A randomized clinical trial found that low-cost letters encouraging individuals to complete the enrollment process resulted in a significant increase in health insurance enrollment. The study suggests that such letters could be an effective tool for promoting health insurance coverage, particularly among underserved populations.

SourceJAMA Network·JournalJAMA Health Forum·DateMar 4, 2022

‘Prescribe ivermectin for COVID-19 only in large-scale randomized trials’

Researchers from Florida Atlantic University advise against prescribing ivermectin to treat or prevent COVID-19 due to the lack of reliable evidence. They emphasize the importance of relying on proven therapeutic innovations and vaccinations to combat the pandemic, citing the risks of unproven treatments like ivermectin.

SourceFlorida Atlantic University·JournalTherapeutic Innovation & Regulatory Science·TypeCase study·DateFeb 16, 2022

Smartphone reminders can improve memory for older adults with dementia

A recent study found that using personal assistant applications on smartphones can significantly improve memory in older adults with dementia. The researchers trained participants to use the technology to receive reminders about daily events and activities, resulting in improved memory performance.

SourceUniversity of Missouri-Columbia·JournalJournal of the American Geriatrics Society·TypeRandomized controlled/clinical trial·DateFeb 7, 2022

Starting physical activity three days post-concussion is safe, has better outcomes

A new study published in the British Journal of Sports Medicine found that resuming non-contact physical activity 72 hours after a concussion is safe for children and youth. The study, which involved 456 participants, showed that early return to physical activity can reduce symptoms and delayed recovery.

SourceUniversity of Ottawa·JournalBritish Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateJan 26, 2022

Children’s Hospital Colorado study explores methods to help reduce injury following successful post-concussion return-to-play

A Children's Hospital Colorado study explores a neuromuscular training intervention to reduce injury risk in athletes returning from sports-related concussions. The research found that athletes who completed the 8-week training program had a significantly lower risk of time-loss injuries compared to those who did not participate.

SourceChildren's Hospital Colorado·JournalThe American Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateJan 21, 2022

Prolonged exposure or cognitive processing therapy?

A landmark VA study found that prolonged exposure was statistically more effective than cognitive processing therapy in easing PTSD symptoms, with most Veterans showing meaningful improvement from both treatments. The researchers recommended shared decision-making between clinicians and patients to select their preferred treatment.

SourceVeterans Affairs Research Communications·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJan 19, 2022

Remdesivir for COVID-19 found to reduce need for mechanical ventilation: RCT

A randomized controlled trial found that remdesivir reduced the need for mechanical ventilation in hospitalized patients with COVID-19. The study involved 1282 patients and showed that those treated with remdesivir were able to come off oxygen and ventilators sooner than those receiving standard care.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeRandomized controlled/clinical trial·DateJan 19, 2022

Easy-to-take medicine better at suppressing HIV in children

A global trial led by UCL found that a dolutegravir-based regimen reduced treatment failure among young people aged three to 18 by around 40% compared to standard treatments. The study also showed better growth and lipid profiles in children receiving dolutegravir, making it an effective option for treating HIV in children.

SourceUniversity College London·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 29, 2021

THE LANCET: Six different COVID-19 boosters are safe and increase immunity when given after two doses of AstraZeneca or Pfizer-BioNTech, with large variations in immune responses, UK trial shows

A UK trial shows six different COVID-19 boosters are safe and stimulate strong immune responses in people who have previously received a two-dose course of ChAdOx1-nCov19 or BNT162b2, according to the first randomised trial of boosters given after two doses. The study found varying levels of protection against COVID-19 infection and ho...

SourceThe Lancet·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateDec 2, 2021

Which COVID-19 vaccine works better?

The study found that the Moderna vaccine offered a lower risk of documented infection (21% reduced), symptomatic COVID-19 (44% reduced), hospitalization (55% reduced), ICU admission (10% reduced), and death (2% reduced) compared to the Pfizer vaccine. The results suggest that either vaccine is effective, but Moderna may be slightly mor...

SourceVeterans Affairs Research Communications·JournalNew England Journal of Medicine·TypeNews article·DateDec 1, 2021

Texas Heart Institute presents paradigm-shifting, late-breaking heart failure therapy research at the American Heart Association annual meeting

Researchers at the Texas Heart Institute have made significant breakthroughs in treating persistent heart failure with a novel stem cell therapy. The phase 3 clinical trial results show that this treatment has the potential to alter the natural history of heart disease, reducing hospitalizations and improving patient outcomes.

SourceTexas Heart Institute·TypeExperimental study·DateNov 15, 2021

Common blood pressure drug does not slow down the progression of more advanced Alzheimer’s, study finds

A phase 2 clinical trial found that losartan, commonly used to treat high blood pressure, did not significantly slow down the progression of Alzheimer's disease in people with mild-to-moderate symptoms. However, the drug may still be beneficial for those with early-stage disease if prescribed for longer periods.

SourceUniversity of Bristol·JournalThe Lancet Neurology·TypeRandomized controlled/clinical trial·DateNov 15, 2021

Penicillin slows devastating impacts of rheumatic heart disease in children from Uganda

A large-scale trial found that penicillin can prevent progression of latent rheumatic heart disease in Ugandan children. The study enrolled 818 children and showed that early detection coupled with prophylactic treatment significantly reduced worsened heart conditions, offering hope for addressing this neglected disease.

SourceChildren's National Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 13, 2021

Capturing a true picture of wolves in Yellowstone: Reevaluating aspen recovery

Aspen recovery in Yellowstone National Park has been found to be less robust than previously believed due to biased sampling methods. Random sampling of all young aspen within a stand revealed a slower rate of recovery compared to the five tallest young aspen, which were used in previous studies.

The Lancet Global Health: Treatment of COVID-19 with fluvoxamine reduces risk of prolonged hospitalization, finds largest trial to date

The largest trial to date shows that fluvoxamine treatment for high-risk outpatients with early-diagnosed COVID-19 reduces the need for prolonged observation or hospitalization. The study found an absolute reduction in risk of prolonged hospitalization and a relative risk reduction of 32% compared to the control group.

SourceThe Lancet·JournalThe Lancet Global Health·TypeRandomized controlled/clinical trial·DateOct 27, 2021

This laser is supposed to rejuvenate vaginal tissue. But scientists say it’s no better than a placebo

A new trial has found that vaginal laser therapy treatments claim to reduce negative vaginal symptoms of menopause – experienced by about half of all women – by up to 100 per cent. However, the study shows they might not work at all, with no difference found between the laser treatment and a placebo.

SourceUniversity of New South Wales·JournalJAMA·TypeRandomized controlled/clinical trial·DateOct 12, 2021

‘Stop prescribing hydroxychloroquine for COVID-19’

Researchers from Florida Atlantic University's Schmidt College of Medicine review recent randomized trials, concluding that hydroxychloroquine poses significant harm in treating COVID-19. The study suggests a halt on prescribing the medication, recommending vaccination and masking instead as effective public health strategies.

SourceFlorida Atlantic University·JournalThe American Journal of Medicine·TypeMeta-analysis·DateAug 30, 2021

New research in rural Costa Rica suggests community-based monitoring can improve water management

New research published in PNAS suggests that community-based monitoring can improve water management in rural Costa Rica by reducing groundwater extraction and improving water quality. The program, which used a smartphone application and WhatsApp, showed modest but significant effects after one year.

SourceUniversity of Maryland Baltimore County·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateAug 24, 2021

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms

A NIH study published in The New England Journal of Medicine found that administering convalescent plasma to outpatients with early symptoms of COVID-19 did not prevent disease progression. The trial, which enrolled over 500 participants, showed a significant reduction of less than 2% in disease progression.

SourceNIH/National Heart, Lung and Blood Institute·JournalNew England Journal of Medicine·DateAug 18, 2021

New study shows Transcendental Meditation reduces emotional stress and improves academics

A new randomized controlled trial found that Transcendental Meditation significantly improved emotional stress symptoms, quality of sleep, and English Language Arts academic achievement in high school students. The study showed that meditation was more effective than sustained silent reading in improving academic outcomes.

Aerin Medical announces results of randomized controlled trial supporting VivAer® for treatment of nasal airway obstruction with nasal valve collapse

The VATRAC trial confirms VivAer's safety and efficacy in treating nasal airway obstruction caused by nasal valve collapse. Patients treated with VivAer showed significant improvement in symptoms compared to the control group, with superior responder rates and symptom reduction.

SourceMerryman Communications·JournalInternational Forum of Allergy & Rhinology·DateJul 13, 2021

Setting COVID-19 drug trials up for success

A new modeling study suggests that randomization and early recruitment in COVID-19 clinical trials can help identify effective antiviral drugs. The researchers found that timing of treatment initiation also plays a crucial role, with treatments administered within the first day of symptom onset showing improved outcomes.

SourceKyoto University·JournalPLOS Medicine·DateJul 6, 2021